CoChat

Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery

Majowicz, Anna, Maczuga, Piotr, Kwikkers, Karin L., van der Marel, Sander, van Logtenstein, Richard, Petry, Harald, van Deventer, Sander J., Konstantinova, Pavlina, Ferreira, Valerie · 2013 · The Journal of Gene Medicine
Cited by 71

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background: Muscle represents an important tissue target for adeno‐associated virus (AAV) vector‐mediated gene transfer in muscular, metabolic or blood‐related genetic disorders. However, several studies have demonstrated the appearance of immune responses against the transgene product after intramuscular AAV vector delivery that resulted in a limited efficacy of the treatment. Use of microRNAs that are specifically expressed in antigen‐presenting cells (APCs) is a promising approach for avoiding those immune responses. Cellular mir‐142‐3p, which is APC‐specific, is able to repress the translation of its target cellular transcripts by binding to a specific target sequences. Methods: In the present study, we explored the potential of mir‐142‐3p specific target sequences with respect to reducing or abolishing immune responses directed against ovalbumin (OVA), a highly immunogenic protein, expressed as transgene and delivered by AAV1 vector administered intramuscularly. Results: The occurrence of immune responses against OVA transgene following intramuscular delivery by AAV have been described previously and resulted in the loss of OVA protein expression. In the present study, we demonstrate that OVA protein expression was maintained when mir‐142‐3pT sequences were incorporated into the expression cassette. The sustained expression of OVA protein over time correlated with a reduced increase in anti‐OVA antibody levels. Furthermore, no cellular infiltrates were observed in the muscle tissue when AAV1 vectors containing four or eight repeats of mir‐142‐3p target sequences after the OVA sequence were used. Conclusions: The rising humoral and cellular immune responses against OVA protein after intramuscular delivery can be efficiently reduced by the use of mir‐142‐3p target sequences. Copyright © 2013 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jgm.2712

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. 10.1182/blood-2009-12-261156 · DOI · Paper page
  2. 10.1182/blood-2011-09-377630 · DOI · Paper page
  3. 10.1182/blood-2008-10-181479 · DOI · Paper page
  4. 10.1126/science.1104297 · DOI · Paper page
  5. 10.1089/hum.2004.15.906 · DOI · Paper page
  6. 10.1089/hum.2006.17.487 · DOI · Paper page
  7. 10.1016/j.atherosclerosissup.2010.03.004 · DOI
  8. 10.1016/j.neulet.2012.04.078 · DOI · Paper page
  9. 10.1089/hum.2007.042 · DOI · Paper page
  10. 10.1073/pnas.93.24.14082 · DOI · Paper page
  11. 10.1046/j.1365-2141.1996.6192064.x · DOI
  12. 10.1038/mt.2010.73 · DOI · Paper page
  13. 10.1111/j.1365-2516.2008.01917.x · DOI
  14. 10.1182/blood.V97.12.3733 · DOI · Paper page
  15. 10.1038/sj.gt.3302539 · DOI
  16. 10.1073/pnas.0909520106 · DOI · Paper page
  17. 10.1182/blood-2004-03-0848 · DOI · Paper page
  18. 10.1038/sj.gt.3301829 · DOI
  19. 10.1038/mt.2009.150 · DOI · Paper page
  20. 10.1056/NEJMra064928 · DOI · Paper page
  21. 10.1016/S0092-8674(01)00616-X · DOI · Paper page
  22. 10.1038/nrg1328 · DOI · Paper page
  23. 10.1126/science.1091903 · DOI · Paper page
  24. 10.1016/S0960-9822(02)00809-6 · DOI · Paper page
  25. 10.1182/blood-2009-04-214569 · DOI · Paper page
  26. 10.1038/mt.2010.290 · DOI · Paper page
  27. 10.1089/10430340260355347 · DOI · Paper page
  28. 10.1128/JVI.70.11.8098-8108.1996 · DOI · Paper page
  29. 10.1128/JVI.70.11.8098-8108.1996 · DOI · Paper page
  30. 10.1182/blood-2004-03-0848 · DOI · Paper page
  31. 10.1006/clim.1999.4724 · DOI · Paper page
  32. Manning WC, 1997, Genetic immunization with adeno‐associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D, J Virol, 71, 7960, 10.1128/jvi.71.10.7960-7962.1997 · DOI · Paper page
  33. 10.1128/JVI.75.1.269-277.2001 · DOI · Paper page
  34. 10.1089/1043034041648453 · DOI · Paper page
  35. 10.1006/mthe.2001.0496 · DOI · Paper page
  36. 10.1038/nrg1379 · DOI · Paper page
  37. 10.1016/S0960-9822(02)00809-6 · DOI · Paper page
  38. 10.1038/nbt1372 · DOI · Paper page
  39. 10.1371/journal.pone.0033286 · DOI
  40. Boisgerault F, 2010, Impact of the Host Environment on the Control of Gene Transfer-Induced Immune Responses with miRNA 142.3p‐Regulated Vectors, Mol Ther, 18, S1

Cited by

See all 71

Metadata

Authors
Majowicz, A., Maczuga, P., Kwikkers, K. L., van der Marel, S., van Logtenstein, R., Petry, H., van Deventer, S. J., Konstantinova, P., & Ferreira, V.
Venue
The Journal of Gene Medicine
Publisher
Wiley
Published
2013-06
Volume
15
Issue
6-7
Pages
219-232
ISSN
  • 1099-498X (ISSN-L)
  • 1521-2254
OpenAlex
W1519797983
Cited by
71
References
18
FWCI
2.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.